News
0
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the Angecy regarding its biosimilar for...
0
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist (trametinib) in...
0
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was steepest in areas where HIV testing was...
0
4.3 million people in the EU are affected by rare cancers, and an estimated 500,000 new cases are diagnosed annually; Dr Terese Johansson highlights...
Features
Pharmafocus caught up with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss...
Featured Appointment
Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of Health. He will replace...
Service Company News
Featured Event
19/09/2017 - 21/09/2017 -
Boston, MA,
@Pharmafocus
